| Title |
Immunotherapy for HER2-positive breast cancer: recent advances and combination therapeutic approaches
|
|---|---|
| Published in |
Breast cancer targets and therapy, January 2019
|
| DOI | 10.2147/bctt.s175360 |
| Pubmed ID | |
| Authors |
Nehad M Ayoub, Kamal M Al-Shami, Rami J Yaghan |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | 33% |
| Unknown | 2 | 67% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 2 | 67% |
| Practitioners (doctors, other healthcare professionals) | 1 | 33% |
Mendeley readers
The data shown below were compiled from readership statistics for 179 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 179 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 21 | 12% |
| Student > Bachelor | 20 | 11% |
| Student > Master | 18 | 10% |
| Researcher | 14 | 8% |
| Student > Doctoral Student | 10 | 6% |
| Other | 28 | 16% |
| Unknown | 68 | 38% |
| Readers by discipline | Count | As % |
|---|---|---|
| Biochemistry, Genetics and Molecular Biology | 31 | 17% |
| Medicine and Dentistry | 20 | 11% |
| Pharmacology, Toxicology and Pharmaceutical Science | 13 | 7% |
| Agricultural and Biological Sciences | 12 | 7% |
| Immunology and Microbiology | 11 | 6% |
| Other | 18 | 10% |
| Unknown | 74 | 41% |
Attention Score in Context
This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 August 2022.
All research outputs
#6,499,906
of 25,385,509 outputs
Outputs from Breast cancer targets and therapy
#82
of 324 outputs
Outputs of similar age
#124,593
of 446,429 outputs
Outputs of similar age from Breast cancer targets and therapy
#2
of 8 outputs
Altmetric has tracked 25,385,509 research outputs across all sources so far. This one has received more attention than most of these and is in the 74th percentile.
So far Altmetric has tracked 324 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.0. This one has gotten more attention than average, scoring higher than 74% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 446,429 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 71% of its contemporaries.
We're also able to compare this research output to 8 others from the same source and published within six weeks on either side of this one. This one has scored higher than 6 of them.